Princeton Global Asset Management LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Princeton Global Asset Management LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$4,000
-20.0%
2,0000.0%0.00%
-50.0%
Q2 2022$5,000
-70.6%
2,000
-64.3%
0.00%
-60.0%
Q1 2022$17,000
+112.5%
5,600
+180.0%
0.01%
+150.0%
Q4 2021$8,000
-11.1%
2,0000.0%0.00%
-33.3%
Q3 2021$9,000
+50.0%
2,0000.0%0.00%
+50.0%
Q2 2021$6,000
-14.3%
2,0000.0%0.00%0.0%
Q1 2021$7,0000.0%2,0000.0%0.00%0.0%
Q4 2020$7,0002,0000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Two Seas Capital LP 825,569$3,211,0002.46%
GREAT POINT PARTNERS LLC 668,907$2,602,0000.58%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 270,000$1,050,0000.47%
QCM Cayman, Ltd. 10,205$40,0000.24%
Pitti Group Wealth Management, LLC 50,000$195,0000.22%
RTW INVESTMENTS, LP 2,504,493$9,742,0000.14%
Hudson Bay Capital Management LP 1,805,700$7,024,0000.07%
Quinn Opportunity Partners LLC 276,485$1,076,0000.07%
Kepos Capital LP 200,000$778,0000.06%
XTX Topco Ltd 29,026$113,0000.06%
View complete list of ARBUTUS BIOPHARMA CORP shareholders